Novavax soars on $1.2 billion Sanofi vaccine licensing deal
Yahoo Finance -

Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.

Related Articles

Latest in News

More from Yahoo Finance | Sanofi Bloomberg Novavax Inc licensing agreement Vaccine Novavax Inc NASDAQ:NVAX